David Jasmund

E: djasmund@pcecompanies.com

Follow me: LinkedIn

Largest Transactions Closed

  • Target
  • Buyer
  • Value($mm)
  • Catalent, Inc.
  • Novo Holdings A/S
  • $16,704.29
  • R1 RCM Inc.
  • Clayton, Dubilier & Rice, LLC; TowerBrook Capital Partners L.P.
  • $6,924.97
  • Axonics, Inc.
  • Boston Scientific Corporation
  • $3,700.59
  • Longboard Pharmaceuticals, Inc.
  • Langkawi Corporation
  • $2,653.17
  • PetIQ, Inc.
  • Bansk Group LLC
  • $1,445.41
  • Aliada Therapeutics, Inc.
  • AbbVie Inc.
  • $1,400.00
  • Modifi Biosciences, Inc.
  • Merck & Co., Inc.
  • $1,330.00
  • Reneo Pharmaceuticals, Inc.
  • OnKure Therapeutics, Inc.
  • $1,301.63
  • AdvancedMD, Inc.
  • Francisco Partners Management, L.P.
  • $1,125.00
  • Integrated Oncology Network, LLC
  • Cardinal Health, Inc.
  • $1,115.00

Other Financial Buyer Transactions Closed

  • Target
  • Buyer
  • Value($mm)
  • Resonant Clinical Solutions
  • Audax Management Company, LLC
  • $650.00
  • Sharecare, Inc.
  • Altaris, LLC
  • $617.86
  • Hamilton Thorne Ltd.
  • Astorg Asset Management S A.R.L.; FAX Capital Corp.
  • $286.87
  • 10 assisted living and memory care communities in North Carolina
  • National Health Investors, Inc.
  • $121.30
  • Manufacturing Facility and Reagent Supply in Huntsville, Alabama of Nektar Therapeutics
  • Ampersand Management LLC
  • $90.00

Other Strategic Buyer Transactions Closed

  • Target
  • Buyer
  • Value($mm)
  • Kate Therapeutics Inc.
  • Novartis AG
  • $1,100.00
  • Brookwood Baptist Health, Inc.
  • Orlando Health, Inc.
  • $910.00
  • Mountain High Products, LLC
  • Canopy USA, LLC
  • $297.50
  • Select Laboratory Assets of OhioHealth
  • Quest Diagnostics Incorporated 
  • $200.00
  • Black Hills Surgical Hospital, LLP
  • Sanford Health
  • $194.00

 

Source S&P Capital IQ as of 1/17/2025 and PCE Proprietary Data

PCE Transactions

Contacts

David Jasmund

Orlando Office

407-621-2111 |

Read More

Jon Gogolak

Orlando Office

407-621-2136 |

Read More

Data Assumptions

This report represents transaction activity as mergers & acquisitions, consolidations, restructurings and spin-offs. Targets are defined as U.S. Based companies with either foreign or U.S. based buyers. Transaction information provided is based on closed dates only.

Glossary

EBIT - Earnings Before Interest and Taxes
EBITDA - Earnings Before Interest, Taxes, Depreciation, Amortization
LTM - Last Twelve Months
TEV - Total Enterprise Value

Sources:

  1. 1. Philips Editorial Team “10 healthcare technology trends for 2025.” Philips, 3 December, 2024.
  2. 2. Han J. “The number of AI medical devices has spiked in the past decade.” Healthcare Dive, 9 October, 2024.
  3. 3. Gooch K. “Orlando Health acquires 3 Steward Florida hospitals.” Beckers Hospital Review, October 24, 2024.
  4. 4. Orlando Health. “Orlando Health Completes Purchase of Hospitals and Physician Practices in East Central Florida.” Orlando Health, 24 October, 2024.
  5. 5. Janisch A. “2025 US health care outlook.” Deloitte, 12 December, 2024.
  6. 6. PWC. “Health services: US Deals 2025 outlook.” PWC, 15 November, 2024.